{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T18:19:04Z","timestamp":1790705944313,"version":"4.1.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/j.ejphar.2016.11.043","type":"journal-article","created":{"date-parts":[[2016,11,25]],"date-time":"2016-11-25T16:16:53Z","timestamp":1480090613000},"page":"201-208","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Cyclic AMP (cAMP) confers drug resistance against DNA damaging agents via PKAIA in CML cells"],"prefix":"10.1016","volume":"794","author":[{"given":"Ling-Yi","family":"Xiao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wai-Ming","family":"Kan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2016.11.043_bib1","doi-asserted-by":"crossref","first-page":"5452","DOI":"10.1210\/en.2004-0900","article-title":"Minireview: PRKAR1A: normal and abnormal functions","volume":"145","author":"Bossis","year":"2004","journal-title":"Endocrinology"},{"key":"10.1016\/j.ejphar.2016.11.043_bib2","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1097\/FPC.0000000000000084","article-title":"cAMP regulates expression of the cyclic nucleotide transporter MRP4 (ABCC4) through the EPAC pathway","volume":"24","author":"Broderdorf","year":"2014","journal-title":"Pharm. Genom."},{"key":"10.1016\/j.ejphar.2016.11.043_bib3","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1038\/emm.2005.74","article-title":"Radiosensitization by targeting radioresistance-related genes with protein kinase A inhibitor in radioresistant cancer cells","volume":"37","author":"Chin","year":"2005","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.ejphar.2016.11.043_bib4","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1034\/j.1600-0773.2000.d01-10.x","article-title":"Cyclic adenosine monophosphate inhibits ursolic acid-induced apoptosis via activation of protein kinase A in human leukaemic HL-60 cells","volume":"86","author":"Choi","year":"2000","journal-title":"Pharm. Toxicol."},{"key":"10.1016\/j.ejphar.2016.11.043_bib5","doi-asserted-by":"crossref","first-page":"35394","DOI":"10.1074\/jbc.M302179200","article-title":"cAMP analog mapping of Epac1 and cAMP kinase. Discriminating analogs demonstrate that Epac and cAMP kinase act synergistically to promote PC-12 cell neurite extension","volume":"278","author":"Christensen","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2016.11.043_bib6","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1038\/cdd.2010.35","article-title":"p53-family proteins and their regulators: hubs and spokes in tumor suppression","volume":"17","author":"Collavin","year":"2010","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.ejphar.2016.11.043_bib7","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1038\/ncb874","article-title":"A novel Epac-specific cAMP analogue demonstrates independent regulation of Rap1 and ERK","volume":"4","author":"Enserink","year":"2002","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.ejphar.2016.11.043_bib8","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.leukres.2009.09.005","article-title":"Protein kinase A activators and the pan-PPAR agonist tetradecylthioacetic acid elicit synergistic anti-leukaemic effects in AML through CREB","volume":"34","author":"Erikstein","year":"2010","journal-title":"Leuk. Res."},{"key":"10.1016\/j.ejphar.2016.11.043_bib9","first-page":"94","article-title":"Elevation of cAMP levels inhibits doxorubicin-induced apoptosis in Pre- B ALL NALM- 6 cells through induction of BAD phosphorylation and inhibition of P53 accumulation","volume":"4","author":"Fatemi","year":"2015","journal-title":"Int. J. Mol. Cell Med."},{"key":"10.1016\/j.ejphar.2016.11.043_bib10","doi-asserted-by":"crossref","first-page":"e516","DOI":"10.1038\/cddis.2013.39","article-title":"Cyclic AMP can promote APL progression and protect myeloid leukemia cells against anthracycline-induced apoptosis","volume":"4","author":"Gausdal","year":"2013","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ejphar.2016.11.043_bib11","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1038\/21690","article-title":"The tyrosine kinase c-Abl regulates p73 in apoptotic response to cisplatin-induced DNA damage","volume":"399","author":"Gong","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2016.11.043_bib12","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1189\/jlb.0109048","article-title":"Epac inhibits apoptosis of human leukocytes","volume":"86","author":"Grandoch","year":"2009","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.ejphar.2016.11.043_bib13","doi-asserted-by":"crossref","first-page":"16665","DOI":"10.1074\/jbc.M414323200","article-title":"Identification of protein kinase A catalytic subunit beta as a novel binding partner of p73 and regulation of p73 function","volume":"280","author":"Hanamoto","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2016.11.043_bib14","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.yjmcc.2010.10.010","article-title":"PKA and Epac synergistically inhibit smooth muscle cell proliferation","volume":"50","author":"Hewer","year":"2011","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.ejphar.2016.11.043_bib15","doi-asserted-by":"crossref","first-page":"12791","DOI":"10.1073\/pnas.0805167105","article-title":"EPAC and PKA allow cAMP dual control over DNA-PK nuclear translocation","volume":"105","author":"Huston","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ejphar.2016.11.043_bib16","doi-asserted-by":"crossref","first-page":"12443","DOI":"10.1073\/pnas.1209538109","article-title":"Localization and quaternary structure of the PKA RIbeta holoenzyme","volume":"109","author":"Ilouz","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ejphar.2016.11.043_bib17","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/j.molcel.2014.05.030","article-title":"PKA-mediated phosphorylation of ATR promotes recruitment of XPA to UV-induced DNA damage","volume":"54","author":"Jarrett","year":"2014","journal-title":"Mol. Cell"},{"key":"10.1016\/j.ejphar.2016.11.043_bib18","doi-asserted-by":"crossref","first-page":"37370","DOI":"10.1074\/jbc.M703697200","article-title":"Protein kinase A, not Epac, suppresses hedgehog activity and regulates glucocorticoid sensitivity in acute lymphoblastic leukemia cells","volume":"282","author":"Ji","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2016.11.043_bib19","doi-asserted-by":"crossref","first-page":"21920","DOI":"10.1074\/jbc.M803193200","article-title":"Protein kinase A (PKA) isoform RIIbeta mediates the synergistic killing effect of cAMP and glucocorticoid in acute lymphoblastic leukemia cells","volume":"283","author":"Ji","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2016.11.043_bib20","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/0145-2126(93)90161-D","article-title":"Mutational inactivation of the p53 gene in the human erythroid leukemic K562 cell line","volume":"17","author":"Law","year":"1993","journal-title":"Leuk. Res."},{"key":"10.1016\/j.ejphar.2016.11.043_bib21","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1002\/ijc.25646","article-title":"PRKAR1A is overexpressed and represents a possible therapeutic target in human cholangiocarcinoma","volume":"129","author":"Loilome","year":"2011","journal-title":"Int. J. Cancer J. Int. Cancer"},{"key":"10.1016\/j.ejphar.2016.11.043_bib22","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1007\/s12013-013-9557-0","article-title":"Regulation of p38, PKC\/Foxo3a\/p73 signaling network by GTP during erythroid differentiation in chronic myelogenous leukemia","volume":"67","author":"Meshkini","year":"2013","journal-title":"Cell Biochem. Biophys."},{"key":"10.1016\/j.ejphar.2016.11.043_bib23","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1182\/blood-2009-02-204883","article-title":"Activation of cAMP signaling inhibits DNA damage-induced apoptosis in BCP-ALL cells through abrogation of p53 accumulation","volume":"114","author":"Naderi","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.ejphar.2016.11.043_bib24","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s12943-014-0278-9","article-title":"Bone marrow stroma-derived PGE2 protects BCP-ALL cells from DNA damage-induced p53 accumulation and cell death","volume":"14","author":"Naderi","year":"2015","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.ejphar.2016.11.043_bib25","doi-asserted-by":"crossref","first-page":"233","DOI":"10.3109\/08923979909052760","article-title":"Increased intracellular cAMP renders HL-60 cells resistant to cytotoxicity of taxol","volume":"21","author":"Pae","year":"1999","journal-title":"Immunopharmacol. Immunotoxicol."},{"key":"10.1016\/j.ejphar.2016.11.043_bib26","doi-asserted-by":"crossref","first-page":"33758","DOI":"10.1074\/jbc.M110667200","article-title":"p73beta is regulated by protein kinase Cdelta catalytic fragment generated in the apoptotic response to DNA damage","volume":"277","author":"Ren","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2016.11.043_bib27","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1007\/s10495-009-0417-8","article-title":"Inhibitory role of cAMP on doxorubicin-induced apoptosis in pre-B ALL cells through dephosphorylation of p53 serine residues","volume":"15","author":"Safa","year":"2010","journal-title":"Apoptosis: Int. J. Program. Cell Death"},{"key":"10.1016\/j.ejphar.2016.11.043_bib28","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/(SICI)1097-4652(199810)177:1<85::AID-JCP9>3.0.CO;2-A","article-title":"Isozymes of cyclic AMP-dependent protein kinases (PKA) in human lymphoid cell lines: levels of endogenous cAMP influence levels of PKA subunits and growth in lymphoid cell lines","volume":"177","author":"Skalhegg","year":"1998","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.ejphar.2016.11.043_bib29","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.1182\/blood-2003-06-2154","article-title":"Among circulating hematopoietic cells, B-CLL uniquely expresses functional EPAC1, but EPAC1-mediated Rap1 activation does not account for PDE4 inhibitor-induced apoptosis","volume":"103","author":"Tiwari","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.ejphar.2016.11.043_bib30","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1182\/blood.V71.1.230.230","article-title":"Site-selective cAMP analogs at micromolar concentrations induce growth arrest and differentiation of acute promyelocytic, chronic myelocytic, and acute lymphocytic human leukemia cell lines","volume":"71","author":"Tortora","year":"1988","journal-title":"Blood"},{"key":"10.1016\/j.ejphar.2016.11.043_bib31","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/sj.bjc.6601909","article-title":"Activation of protein kinase A (PKA) by 8-Cl-cAMP as a novel approach for antileukaemic therapy","volume":"91","author":"Weissinger","year":"2004","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ejphar.2016.11.043_bib32","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1006\/bbrc.1993.1085","article-title":"Cyclic adenosine 3',5'-monophosphate, a second messenger in interleukin-1 mediated K562 cytostasis","volume":"190","author":"Weitzmann","year":"1993","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejphar.2016.11.043_bib33","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1046\/j.1365-2141.2000.01903.x","article-title":"Constitutive levels of cAMP-dependent protein kinase activity determine sensitivity of human multidrug-resistant leukaemic cell lines to growth inhibition and apoptosis by forskolin and tumour necrosis factor alpha","volume":"108","author":"Yin","year":"2000","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.ejphar.2016.11.043_bib34","doi-asserted-by":"crossref","first-page":"20858","DOI":"10.1074\/jbc.M310643200","article-title":"The pro-apoptotic protein Bim is a convergence point for cAMP\/protein kinase A- and glucocorticoid-promoted apoptosis of lymphoid cells","volume":"279","author":"Zhang","year":"2004","journal-title":"J. Biol. Chem."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299916307580?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299916307580?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,14]],"date-time":"2022-07-14T19:36:23Z","timestamp":1657827383000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299916307580"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":34,"alternative-id":["S0014299916307580"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2016.11.043","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cyclic AMP (cAMP) confers drug resistance against DNA damaging agents via PKAIA in CML cells","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2016.11.043","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}